PRAXPraxis Precision Medicines, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 20325
Ticker: PRAX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-10-16
Round lot: 40
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: PRAX

Detail

Enriched 2026-08-14 20:47

Market cap: $10,770,406,759.42
Shares outstanding (class): 27,919,988
Shares outstanding (weighted): 27,878,774
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 10,998
Location: BOSTON, MA
Homepage: https://www.praxismedicines.com
Description: Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Market cap and share counts drift.

Funds holding this security

192 funds · 197 positions · $2.05B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$285.20M	0.01%	885,186 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$203.17M	0.28%	630,599 NS	FIGI
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$127.26M	2.45%	394,970 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$103.45M	0.06%	321,085 NS	FIGI
Janus Henderson Enterprise Fund JANUS INVESTMENT FUND	—	$93.57M	0.46%	290,420 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$92.67M	0.11%	287,621 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$91.91M	1.24%	285,252 NS	FIGI
Janus Henderson Triton Fund JANUS INVESTMENT FUND	—	$78.52M	1.51%	243,708 NS	FIGI
VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS	VBR	$65.88M	0.11%	204,468 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$65.71M	0.53%	203,935 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$62.86M	0.77%	195,097 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$60.99M	0.56%	189,301 NS	FIGI
Hood River Small-Cap Growth Fund Manager Directed Portfolios	—	$60.52M	1.16%	187,831 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$52.65M	0.41%	163,400 NS	FIGI
Janus Henderson Venture Fund JANUS INVESTMENT FUND	—	$45.44M	1.48%	141,046 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERPRAX
FIGI_COMPOSITEBBG00W9LF2G5
FIGI_SHARE_CLASSBBG00W9LF2H4
CIK0001689548
ISINUS74006W2070
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a pharmaceutical preparation firm as indicated by its SIC code and common stock instrument type.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.